Platform
Features
1 follower
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.
Industries
Headquarters
Employees
Links
3 members
2 members
Calico
6 followers
Tessera Therapeutics
2 followers
Vaxcyte
Septerna
Vera Therapeutics
89bio
Day One Biopharmaceuticals
Caribou Biosciences
Cargo
Capricor Therapeutics
Apogee Therapeutics
Explore companies